Correlation Between OBI Pharma and Intech Biopharm

Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Intech Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Intech Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OBI Pharma and Intech Biopharm, you can compare the effects of market volatilities on OBI Pharma and Intech Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Intech Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Intech Biopharm.

Diversification Opportunities for OBI Pharma and Intech Biopharm

-0.16

Correlation Coefficient

OBI Pharma  Intech Biopharm

Good diversification

The 3 months correlation between OBI and Intech is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Intech Biopharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intech Biopharm and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Intech Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intech Biopharm has no effect on the direction of OBI Pharma i.e., OBI Pharma and Intech Biopharm go up and down completely randomly.

Pair Corralation between OBI Pharma and Intech Biopharm

Assuming the 90 days trading horizon OBI Pharma is expected to generate 1.08 times more return on investment than Intech Biopharm. However, OBI Pharma is 1.08 times more volatile than Intech Biopharm. It trades about 0.08 of its potential returns per unit of risk. Intech Biopharm is currently generating about -0.19 per unit of risk. If you would invest  5,660  in OBI Pharma on December 30, 2024 and sell it today you would earn a total of  390.00  from holding OBI Pharma or generate 6.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

OBI Pharma  vs.  Intech Biopharm

OBI Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in OBI Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, OBI Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Intech Biopharm

Risk-Adjusted Performance

Very Weak

Over the last 90 days Intech Biopharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with OBI Pharma and Intech Biopharm

The main advantage of trading using opposite OBI Pharma and Intech Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Intech Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intech Biopharm will offset losses from the drop in Intech Biopharm's long position.

The idea behind OBI Pharma and Intech Biopharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.